Skip to content

Study · Non-randomized trial · n = 43 · 2007

5 results

[Cerebrolysin treatment of mild cognitive impairment of vascular genesis].

Damulin IV, Mkhitarian EA, Koberskaia NN

Terapevticheskii arkhiv1 Jan 2007

PMID17684971 (opens in a new tab)PepBankPUB-17684971
Publisher pageAsk about this study
Jump to 5 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

5 results from studies that gave the peptide. 5 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with vascular mild cognitive impairment, cerebrolysin improved motor activity, with a delayed effect noticeable 3 months after treatment.

    In plain wordsIn patients with vascular mild cognitive impairment, cerebrolysin improved motor activity, with effects noticeable 3 months after treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseMotor activity
    Study

    n = 43

    Outcome group
    Exercise and physical function · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of the physiological solution · intravenous · 20 injectionsAs given in this study (human).

    Source sentences

    Summary
    Cerebrolysin improved motor activity, memory, attention, general cognitive status.
    4 context sentences
    Summary · context
    The effect is delayed and was noticeable 3 months after the end of the treatment course.
    Summary · context
    The examination covered 43 patients aged 40 to 80 years with mild cognitive impairment.
    Summary · context
    Cerebrolysin was injected in drops intravenously in a dose 10 ml per 200 ml of the physiological solution.
    Summary · context
    The course included 20 injections with immediate assessment of the response and 3 months after the course.
  2. 02HumanNon-randomized trialEfficacy outcome

    In patients with vascular mild cognitive impairment, cerebrolysin improved memory, with a delayed effect noticeable 3 months after treatment.

    In plain wordsIn patients with vascular mild cognitive impairment, cerebrolysin improved memory, with effects noticeable 3 months after treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseMemory
    Study

    n = 43

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of the physiological solution · intravenous · 20 injectionsAs given in this study (human).

    Source sentences

    Summary
    Cerebrolysin improved motor activity, memory, attention, general cognitive status.
    4 context sentences
    Summary · context
    The effect is delayed and was noticeable 3 months after the end of the treatment course.
    Summary · context
    The examination covered 43 patients aged 40 to 80 years with mild cognitive impairment.
    Summary · context
    Cerebrolysin was injected in drops intravenously in a dose 10 ml per 200 ml of the physiological solution.
    Summary · context
    The course included 20 injections with immediate assessment of the response and 3 months after the course.
  3. 03HumanNon-randomized trialEfficacy outcome

    In patients with vascular mild cognitive impairment, cerebrolysin improved attention, with a delayed effect noticeable 3 months after treatment.

    In plain wordsIn patients with vascular mild cognitive impairment, cerebrolysin improved attention, with effects noticeable 3 months after treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseAttention
    Study

    n = 43

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of the physiological solution · intravenous · 20 injectionsAs given in this study (human).

    Source sentences

    Summary
    Cerebrolysin improved motor activity, memory, attention, general cognitive status.
    4 context sentences
    Summary · context
    The effect is delayed and was noticeable 3 months after the end of the treatment course.
    Summary · context
    The examination covered 43 patients aged 40 to 80 years with mild cognitive impairment.
    Summary · context
    Cerebrolysin was injected in drops intravenously in a dose 10 ml per 200 ml of the physiological solution.
    Summary · context
    The course included 20 injections with immediate assessment of the response and 3 months after the course.
  4. 04HumanNon-randomized trialEfficacy outcome

    In patients with vascular mild cognitive impairment, cerebrolysin improved general cognitive status, with a delayed effect noticeable 3 months after treatment.

    In plain wordsIn patients with vascular mild cognitive impairment, cerebrolysin improved general cognitive status, with effects noticeable 3 months after treatment.

    Peptide
    Cerebrolysin
    Outcome
    IncreaseGeneral cognitive status
    Study

    n = 43

    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    10 ml per 200 ml of the physiological solution · intravenous · 20 injectionsAs given in this study (human).

    Source sentences

    Summary
    Cerebrolysin improved motor activity, memory, attention, general cognitive status.
    4 context sentences
    Summary · context
    The effect is delayed and was noticeable 3 months after the end of the treatment course.
    Summary · context
    The examination covered 43 patients aged 40 to 80 years with mild cognitive impairment.
    Summary · context
    Cerebrolysin was injected in drops intravenously in a dose 10 ml per 200 ml of the physiological solution.
    Summary · context
    The course included 20 injections with immediate assessment of the response and 3 months after the course.
  5. 05HumanNon-randomized trialSafety outcome

    In patients with vascular mild cognitive impairment, no side effects were reported during cerebrolysin treatment.

    In plain wordsIn patients with vascular mild cognitive impairment, no side effects were reported with cerebrolysin.

    Peptide
    Cerebrolysin
    Outcome
    Not applicableSide effects
    Study

    n = 43

    Outcome group
    Adverse events · Whole body
    Studied dose
    10 ml per 200 ml of the physiological solution · intravenous · 20 injectionsAs given in this study (human).

    Source sentences

    Summary
    Side effects were absent.
    3 context sentences
    Summary · context
    The examination covered 43 patients aged 40 to 80 years with mild cognitive impairment.
    Summary · context
    Cerebrolysin was injected in drops intravenously in a dose 10 ml per 200 ml of the physiological solution.
    Summary · context
    The course included 20 injections with immediate assessment of the response and 3 months after the course.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.